Skip to content
Lower risk Medical device recall · FDA · Published August 29, 2025

Northeast Scientific NES Reprocessed Laser Catheter Recall: Sterile Packaging Risk

Northeast Scientific recalls NES Reprocessed 1.7mm RX Turbo Elite Laser Atherectomy Catheter (Model R-417-156) due to potential sterile packaging breaches. Affected units sold with expiration dates before August 29, 2026.

🇺🇸 FDA recall #Z-0024-2026Medical deviceNortheast Scientific ›
Take action

Contact the company

Recalling firmNortheast Scientific Inc.2142 Thomaston Ave · Waterbury, CT 06704-1013
✎ GovInfoNow plain-language explainer

What happened, in plain English

Northeast Scientific is recalling its reprocessed laser atherectomy catheter (Model R-417-156) because the sterile packaging might be compromised. This could lead to infections during medical procedures if the device is used without proper sterility. Read more at govinfonow.com/recall/51496-northeast-scientific-nes-reprocessed-laser-catheter-recall-sterile-packaging-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/51496-northeast-scientific-nes-reprocessed-laser-catheter-recall-sterile-packaging-risk · Updated August 17, 2026 · FDA enforcement record: FDA #Z-0024-2026

Cite this page

“Northeast Scientific NES Reprocessed Laser Catheter Recall: Sterile Packaging Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/51496-northeast-scientific-nes-reprocessed-laser-catheter-recall-sterile-packaging-risk. Based on FDA recall #Z-0024-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0024-2026%22&limit=1).

Why it’s dangerous

The sterile packaging may have breaches that compromise the device's sterility. If the packaging is not intact, the catheter could cause infections during medical procedures.

Who’s affected

Healthcare professionals using this catheter for vascular procedures are most at risk. Patients receiving the device during procedures could face infection if the sterile packaging is breached.

How to tell if you have this one

Check for the model number R-417-156 on the packaging. The device was sold with expiration dates before August 29, 2026.

  • Brand
    Northeast Scientific
  • Category
    Medical device
FDA recall event · 8 products

All 8 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide distribution to CA, FL, IL, KS, LA, MD, MI, MO, NC, NJ, NM, NV, NY, PA, TN, TX, VA.
Recall numberProduct, codes & lotsQuantity
Z-0018-2026NES Reprocessed 0.9mm OTW Turbo Elite Laser Atherectomy Catheter. Model Number: R-410-152. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions.; Model No R-410-152; UDI-DI 00850044399055; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026561 units
Z-0019-2026NES Reprocessed 1.4mm OTW Turbo Elite Laser Atherectomy Catheter. Model Number: R-414-151. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-414-151; UDI-DI 00850044399116; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026173 units
Z-0020-2026NES Reprocessed 1.7mm OTW Turbo Elite Laser Atherectomy Catheter. Model Number: R-417-152. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-417-152; UDI-DI 00850044399093; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026165 units
Z-0021-2026NES Reprocessed 2.0mm OTW Turbo Elite Laser Atherectomy Catheter. Model Number: R-420-006. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-420-006; UDI-DI 00850044399079; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026.199 units
Z-0022-2026NES Reprocessed 0.9mm RX Turbo Elite Laser Atherectomy Catheter. Model/Catalog Number: R-410-154. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-410-154; UDI-DI 00850044399062; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026.795 units
Z-0023-2026NES Reprocessed 1.4mm RX Turbo Elite Laser Atherectomy Catheter. Model Number: R-414-159. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-414-159; UDI-DI 00850044399123; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026.1,019 units
Z-0024-2026NES Reprocessed 1.7mm RX Turbo Elite Laser Atherectomy Catheter. Model Number: R-417-156. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-417-156; UDI-DI 00850044399109; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026.616 units
Z-0025-2026NES Reprocessed 2.0mm RX Turbo Elite Laser Atherectomy Catheter. Model Number: R-420-159. The NES Reprocessed Turbo-Elite Laser Atherectomy Catheter is indicated for use in the treatment, including atherectomy, of infrainguinal stenoses and occlusions. This model is not cleared for marketing in the US.; Model No R-420-159; UDI-DI 00850044399086; All Lot Numbers that are within their labeled shelf life with expiration dates prior to 29AUG2026.141 units
Based on the official FDA remedy

What to do — step by step

  1. Check Packaging Integrity

    Inspect the sterile packaging for any signs of damage or breaches.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 17 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: nationwideOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: nationwideALGeorgia: nationwideGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution to CA, FL, IL, KS, LA, MD, MI, MO, NC, NJ, NM, NV, NY, PA, TN, TX, VA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: California, Florida, Illinois, Kansas, Louisiana, Maryland, Michigan, Missouri, Nevada, New Jersey, New Mexico, New York, North Carolina, Pennsylvania, Tennessee, Texas, Virginia.

Recall timeline

FDA published this recall 40 days after the firm started it.

1. Firm started the recall: Aug 29, 202512. FDA classified it Class II: Oct 2, 202523. Published in FDA’s Enforcement Report: Oct 8, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0024-2026 (August 29, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0024-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA